We therefor believe that sutent may play anti-self-renewal and anti-malignancy roles in neuroblastoma tumorspheres by inhibiting the protein expression of the stemness-maintenance drivers, SOX2 and PDGFRβ as well as the malignant, proliferative markers MYCN and survivin. The gene discussed is SOX2; the disease is neuroblastoma.